Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Cancer
Medical News Today
Sunday, April 18, 2010 - 12:19pm
tags:
Circadian Technologies, VGX-100, VEGF-C growth factor, cancer, Docetaxel, Avastin
Akorn, Inc. Announces FDA Approval For Hydromorphone Hydrochloride Injection 10mg/ml In 1ml, 5ml And 50ml Doses
Medical News Today
Sunday, April 18, 2010 - 12:17pm
tags:
Akorn, Dilaudid, hydromorphone hydrochloride
Cyclin-Dependent Cancer Confab Preview
Seeking Alpha
Sunday, April 18, 2010 - 12:13pm
tags:
cyclin-dependent kinase inhibition [CDK], cancer, Pfizer, Cyclacel, Merck, Sanofi, Bayer, Tragara Pharmaceutical
Rexahn Pharma Presents a Landmark in Clinical Trial Data Interpretation
Seeking Alpha
Sunday, April 18, 2010 - 12:06pm
tags:
Rexahn, Serdaxin, antidepressant
AEterna Zentaris to Raise US$15 Million in Registered Direct Offering
PR_USA
Saturday, April 17, 2010 - 1:05pm
tags:
Aeterna Zentaris, stock offering
Quebec's vaunted biotech industry 'dying'
Edmonton Journal, Canada
Saturday, April 17, 2010 - 1:04pm
tags:
biotech
New Drug Applications Approval for Five New Products in Japan
The Financial
Saturday, April 17, 2010 - 1:03pm
tags:
Japan, Nesina, type 2 diabetes, Metact, Unisa, hypertension, Rozerem, insomnia, Vectibix, cancer
Affymax and Takeda Report Phase 2 Analyses of Hematide/peginesatide in Hemodialysis Patients
PharmaLive
Saturday, April 17, 2010 - 12:58pm
tags:
Affymax, Takeda, Hematide/peginesatide, dialysis
Impax Labs amends co-promotion pact with Wyeth for Lyrica
Pharmabiz
Saturday, April 17, 2010 - 12:56pm
tags:
Impax Labs, Wyeth, Lyrica
Quebec, Ontario biotech strategy urged
Montreal Gazette, Canada
Saturday, April 17, 2010 - 12:55pm
tags:
biotech
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Pharmabiz
Saturday, April 17, 2010 - 12:53pm
tags:
Novartis, Emisphere, Eligen Technology, PTH1-34, osteoporosis
US Court favours Par Pharma in Zegerid litigation case
Pharmabiz
Saturday, April 17, 2010 - 12:52pm
tags:
Par Pharmaceutical, Zegrid
RegeneRx Biopharmaceuticals Announces Proposed Public Offering
MarketWatch
Saturday, April 17, 2010 - 12:50pm
tags:
RegeneRx, IPOs
FDA approves BioAlliance Pharma's Oravig for OPC
The Medical News
Saturday, April 17, 2010 - 12:49pm
tags:
BioAlliance, Oravig, oropharyngeal candidiasis
Lawyer Can Sue for Profits From Use of Thalidomide as a Cancer Treatment
law.com
Saturday, April 17, 2010 - 12:41pm
tags:
legal, thalidomide, Celgene
Earnings Preview: Analysts eye Lilly future sales
Yahoo/AP
Saturday, April 17, 2010 - 12:37pm
tags:
Eli Lilly, earnings
It'll Be a Blockbuster! High Fives All Around, Right?
Motley Fool
Saturday, April 17, 2010 - 12:36pm
tags:
drug development, Sanofi, lixisenatide
Bristol-Myers Squibb to Post Select Investigational Compound Data Updates on Company Website
Yahoo/BusinessWire
Saturday, April 17, 2010 - 12:25pm
tags:
Bristol-Myers Squibb
FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Saturday, April 17, 2010 - 12:23pm
tags:
Tarceva, OSI Pharmaceuticals, non-small cell lung cancer, SATURN
Biotech IPOs On The Mend?
Yahoo/Investor's Business Daily
Saturday, April 17, 2010 - 12:21pm
tags:
biotech, IPOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.